New Treatments for GIST: Finding the Right Combinations
Prior to 2000, surgery was the only known effective treatment for advanced GIST.
LRG researchers publish study on DREAM complex – an important regulator of GIST “cell sleep”
A study about the DREAM complex was published in the June issue of Cancer Research by LRG Research Team members Drs. Anette Duensing and Maria Debiec-Rychter.
GIST Tumors – Surgery May Improve Survival Rate For Imatinib Patients
Resecting GIST tumors may improve survival rates. Surgically removing residual gastrointestinal stromal tumors in patients who respond to imatinib therapy
LRG closes out 2012 in the spotlight: advocacy, support & research highlighted
The Life Raft Group is dedicated to the welfare and survival of GIST patients worldwide and we carry out our mission through research, patient support & education and advocacy. The LRG was highlighted in all three areas at the end of 2012 and we wanted to share the important work we’re doing with all of you.
LRG & colleagues make their mark on 17th annual CTOS meeting in Prague
Representatives from the Life Raft Group recently traveled to Prague, Czech Republic to attend the annual Connective Tissue Oncology Society (CTOS) meeting. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues.
Understanding How GISTs Develop Enables Discovery of New Therapies
By Drs. Sebastian Bauer, West German Cancer Center, University of Essen, Germany and Jonathan Fletcher, Brigham & Women’s Hospital, Harvard University, LRG Research Team Researchers talk plainly about microGISTs, how this cancer develops and what all [...]
Imatinib Plasma Levels Revisited – An editorial post by Jerry Call
Since we have gotten a number of questions about Gleevec (imatinib) plasma levels and testing, I think it’s time to revisit the subject, especially for newer members. Since this is a very complex subject, this may take a few emails and a few days.